Live Breaking News & Updates on Wildon Farwell|Page 3
Stay updated with breaking news from Wildon farwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price […] ....
WALTHAM, Mass., March 27, 2024 Dyne Therapeutics, Inc. , a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically. ....
HC Wainwright reiterated their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $36.00 target price on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2024 earnings at ($0.83) EPS, Q2 2024 earnings at ($0.83) […] ....
Barclays PLC grew its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 21.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 99,574 shares of the company’s stock after purchasing an additional 17,603 shares during the quarter. Barclays PLC’s holdings […] ....
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Up to $22.91 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.